GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,069,973 | +158.5% | 525,075 | +210.0% | 0.01% | +150.0% |
| Q2 2023 | $10,085,004 | -22.0% | 169,382 | -25.8% | 0.00% | 0.0% |
| Q1 2023 | $12,936,576 | +280.3% | 228,400 | +398.7% | 0.00% | +100.0% |
| Q4 2022 | $3,401,566 | -40.7% | 45,800 | -52.4% | 0.00% | 0.0% |
| Q3 2022 | $5,736,000 | +50.9% | 96,288 | +42.2% | 0.00% | 0.0% |
| Q2 2022 | $3,800,000 | -60.0% | 67,700 | -47.4% | 0.00% | -50.0% |
| Q1 2022 | $9,491,000 | -58.3% | 128,636 | -59.2% | 0.00% | +100.0% |
| Q4 2021 | $22,742,000 | +137.6% | 315,000 | +152.2% | 0.00% | 0.0% |
| Q3 2021 | $9,570,000 | -18.6% | 124,900 | -17.6% | 0.00% | 0.0% |
| Q2 2021 | $11,754,000 | +68.7% | 151,600 | +34.2% | 0.00% | 0.0% |
| Q1 2021 | $6,969,000 | -41.4% | 113,004 | -38.0% | 0.00% | 0.0% |
| Q4 2020 | $11,894,000 | -16.0% | 182,362 | -36.2% | 0.00% | -50.0% |
| Q3 2020 | $14,155,000 | -11.3% | 285,859 | -14.5% | 0.00% | -50.0% |
| Q2 2020 | $15,956,000 | +42.2% | 334,453 | +26.8% | 0.00% | 0.0% |
| Q1 2020 | $11,218,000 | -8.5% | 263,770 | +26.7% | 0.00% | +33.3% |
| Q4 2019 | $12,260,000 | +74.1% | 208,233 | +51.2% | 0.00% | +50.0% |
| Q3 2019 | $7,041,000 | -59.1% | 137,747 | -66.1% | 0.00% | +100.0% |
| Q2 2019 | $17,205,000 | +163.6% | 406,752 | +207.9% | 0.00% | -50.0% |
| Q1 2019 | $6,527,000 | +175.2% | 132,100 | +141.1% | 0.00% | +100.0% |
| Q4 2018 | $2,372,000 | -80.4% | 54,800 | -74.3% | 0.00% | -75.0% |
| Q3 2018 | $12,089,000 | +26.2% | 213,000 | +12.2% | 0.00% | +33.3% |
| Q2 2018 | $9,582,000 | +269.1% | 189,900 | +264.5% | 0.00% | +200.0% |
| Q1 2018 | $2,596,000 | -58.1% | 52,100 | -65.5% | 0.00% | -50.0% |
| Q4 2017 | $6,198,000 | +80.6% | 150,800 | +30.6% | 0.00% | 0.0% |
| Q3 2017 | $3,432,000 | +147.3% | 115,491 | +175.8% | 0.00% | +100.0% |
| Q2 2017 | $1,388,000 | +54.4% | 41,870 | +38.0% | 0.00% | – |
| Q1 2017 | $899,000 | -66.0% | 30,349 | -71.5% | 0.00% | -100.0% |
| Q4 2016 | $2,642,000 | +16.8% | 106,500 | +6.3% | 0.00% | 0.0% |
| Q3 2016 | $2,262,000 | -64.2% | 100,231 | -62.2% | 0.00% | -66.7% |
| Q2 2016 | $6,311,000 | +100.4% | 264,879 | +99.8% | 0.00% | +50.0% |
| Q1 2016 | $3,149,000 | +47.6% | 132,565 | +72.9% | 0.00% | +100.0% |
| Q4 2015 | $2,133,000 | -52.2% | 76,668 | -64.5% | 0.00% | -50.0% |
| Q3 2015 | $4,460,000 | -18.9% | 215,868 | +0.8% | 0.00% | 0.0% |
| Q2 2015 | $5,498,000 | -3.7% | 214,152 | -5.4% | 0.00% | 0.0% |
| Q1 2015 | $5,711,000 | +10.3% | 226,288 | +3.9% | 0.00% | +100.0% |
| Q4 2014 | $5,176,000 | +954.2% | 217,759 | +772.9% | 0.00% | – |
| Q3 2014 | $491,000 | -58.9% | 24,948 | -50.1% | 0.00% | -100.0% |
| Q2 2014 | $1,195,000 | +54.4% | 49,947 | +71.6% | 0.00% | – |
| Q1 2014 | $774,000 | +173.5% | 29,115 | +107.3% | 0.00% | – |
| Q4 2013 | $283,000 | -9.6% | 14,044 | -21.5% | 0.00% | – |
| Q3 2013 | $313,000 | +24.7% | 17,900 | +20.1% | 0.00% | – |
| Q2 2013 | $251,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |